Oral Formulation of Angiotensin-(1-7) Promotes Therapeutic Actions in a Model of Eosinophilic and Neutrophilic Asthma.
Magalhães GS, Gregório JF, Cançado Ribeiro ATP, Baroni IF, Vasconcellos AVO, Nakashima GP, Oliveira IFA, de Matos NA, Castro TF, Bezerra FS, Sinisterra RD, Pinho V, Teixeira MM, Santos RAS, Rodrigues-Machado MG, Campagnole-Santos MJ.
Magalhães GS, et al. Among authors: de matos na.
Front Pharmacol. 2021 Mar 8;12:557962. doi: 10.3389/fphar.2021.557962. eCollection 2021.
Front Pharmacol. 2021.
PMID: 33762930
Free PMC article.